5 – NICE approved BMS’s Opdivo for lung cancer
6 – Merck to appeal EU rejection of COVID-19 drug
7 – FDA sued by US states over abortion pill access
8 – Sun Pharma recalls at least 34,000 bottles of generic drug
9 – Wearable sensor helps detect heart attacks
12 – Sooma receives FDA Breakthrough Device designation for depression therapy device

Our Team

Executive Director – PMGroup Worldwide Ltd
Karl Equi

Group Managing Editor
Iona Everson

ieverson@pmlive.com

Editorial Assistants
Betsy Goodfellow

betsy@pharmafile.com
James Spargo
james@samedanltd.com

Sales Manager
Eliot Haynes

eliot@pharmafile.com

Design & Layout
Peter May

designer@samedanltd.com

Pharmafocus is published by:

Samedan Ltd
Suite E, 11 Bell Yard Mews,
175 Bermondsey Street,
London, SE1 3TN
Tel: +44 (0)20 7724 3456
Fax: +44 (0)20 7403 7747

www.pharmafile.com

Subscriptions & Data Management

Curwood CMS Tel: 01580 883840

enquiries@c-cms.com

ISSN: 1465-5403

Pharmafocus is sent free of charge to selected permanent employees of ethical and OTC pharmaceutical and biotech companies. Employees are specifiers from middle and senior management with responsibility for making buying decisions. Selection is at the discretion of the Publisher. Copies are also available on a subscription basis at an annual fee of £115 (UK), £145 (Europe) and £185 (RoW).

All subscriptions payable to Samedan. Back copies can be purchased for £15.00 each. Pharmafocus is published by Samedan Ltd. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form without permission, unless for the purposes of reference and comment.

The opinions and views expressed by contributors to this publication are not necessarily those of the Editor or the Publisher and, while every care has been taken in the preparation of the newspaper, the Editor and the Publisher are not responsible for such opinions and views, or for any inaccuracies in the articles. The Publisher is not responsible for any images supplied by contributors. While every care is taken with artwork supplied, the Publisher cannot be held responsible for any loss or damage incurred. The entire content of this publication is protected by copyright. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form, by any means – electronic, mechanical, photocopying or otherwise – without the prior permission of the Publisher.

Pharmafocus

Categories

Social Footprints